Researchers at the Indian Institute of Technology Bombay have developed a gentler method to recover lab-grown T-cells, a crucial step in CAR T-cell therapy. Using the mild enzyme Accutase instead of harsher alternatives helps improve cell survival and preserve immune function. The approach enhances the reliability and efficiency of immunotherapy production, supports cost reduction, and strengthens India’s efforts to make advanced cancer treatments more affordable and accessible.
Click to View MoreGenerative AI is increasingly embedded in healthcare systems to address workforce shortages, improve efficiency, support clinical decision-making, and accelerate medical research. While it offers significant benefits in documentation, diagnostics, patient engagement, and drug discovery, its adoption raises concerns related to accuracy, bias, data privacy, ethics, and regulation. The future of Generative AI in healthcare therefore depends on responsible governance, strong government initiatives, and human oversight to ensure that technology augments, rather than replaces, clinical judgement and patient trust.
Click to View More
© 2026 iasgyan. All right reserved